322.56MMarket Cap-1.61P/E (TTM)
3.090High3.070Low3.46MVolume3.070Open3.070Pre Close10.65MTurnover3.61%Turnover RatioLossP/E (Static)104.39MShares9.74552wk High-1.98P/B296.43MFloat Cap2.30052wk Low--Dividend TTM95.93MShs Float42.410Historical High--Div YieldTTM0.65%Amplitude2.300Historical Low3.079Avg Price1Lot Size
Revance Therapeutics Stock Forum
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
Crown Laboratories and Revance Therapeutics (NASDAQ: RVNC) have announced an amended merger agreement where Crown will acquire all outstanding Revance shares for $3.10 per share in cash through a tender offer. The amendment comes after several developments, including Revance's settlement with Teoxane regarding distribution agreements and revised brand guidelines, which are expect...
📊⚡️📊
No comment yet